News Medical on MSN7d
EU-funded Vigilant network aims to develop broad-spectrum antiviral drugs
Pandemics threaten both human health and the global economy. Vaccines are an essential part of the fight against pandemics, but they are only available months after the outbreak ...
Trump order set to halt supply of HIV, malaria drugs to poor countries, sources say
The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria and tuberculosis, as well as ...
Investornewsbreaks Nanoviricides (NYSE American: NNVC) Partners With CRO To Advance NV-387 Antiviral Drug To Phase II Trials
NanoViricides, Inc. (NYSE American: NNVC) announced it has engaged a Clinical Research Organization (“CRO”) to conduct a Phase II clinical trial for ...
Yahoo Finance3d
ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research
announces today the publication of an invited review of the preclinical and clinical development of INNA-051 in Antiviral Research, a monthly peer-reviewed medical journal of the International ...
As H5N1 Is Detected In San Francisco, A Panel Discusses Next Steps
San Francisco confirmed that a child in the city became the first case of H5N1. A panel of biotech leaders discussed what ...
NanoViricides Engages CRO for Phase II Clinical Trial
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...